Minocycline, a drug whose pleiotropic effects include the inhibition of MMP-9 activity, reverses filopodia transformation toward mature spines in an animal model of fragile X syndrome (Fmr1 knockout mice). This evidence concerns the gene FMR1 and fragile X syndrome.